YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing, and selling of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, cardiovascular diseases, and others. The company is headquartered in Yichang, Guangdong and currently employs 4,861 full-time employees. The firm's main products include Kewei (Oseltamivir Phosphate Capsules and Granules), Ertongshu (Benzbromarone Tablets), Oumeining (Telmisartan Tablets), Linluoxing (Moxifloxacin Hydrochloride Tablets) and Olmesartan Tablets and other products. The firm is also engaged in the centralized procurement business. The firm mainly conducts its business in the domestic market.
Follow-Up Questions
What is the price performance of YIHCF stock?
The current price of YIHCF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for YiChang HEC ChangJiang Pharmaceutical Co Ltd?
YiChang HEC ChangJiang Pharmaceutical Co Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is YiChang HEC ChangJiang Pharmaceutical Co Ltd market cap?
YiChang HEC ChangJiang Pharmaceutical Co Ltd's current market cap is $0
Is YiChang HEC ChangJiang Pharmaceutical Co Ltd a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for YiChang HEC ChangJiang Pharmaceutical Co Ltd, including 2 strong buy, 4 buy, 1 hold, 0 sell, and 2 strong sell
